Pfizer, Inc. (NYSE:PFE) dropped -0.59% and closed the trade at $ 33.94. The company recorded a trading capacity of 25.62 million shares above its three months average daily volume of 20.74 million shares. During the last trade, shares reached to high price of $34.22 and touched the low price of $33.83. The stock’s 50-day moving average is noted at $35.23 and its 200-day moving average is stands at $33.72.
Additionally, the company has a PE ratio of 30.09 and has EPS of 1.13. The company has market capitalization of $205.87B.
Currently Pfizer, Inc. (PFE) captured an average recommendation of “ Overweight ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “11″ Analysts”. “0” rated “Sell” for the company. “7” said the company as a “Hold”. Overweight rating was given by “4” and Underweight rating was given by “0”.
Analysts are expecting that the company to achieve $39.75 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $54.00 however minimum price target advised by analysts is $33.00. The Median price target for the stock is measured at $39.00.
Presently, Analysts decided consensus EPS estimate of $0.62 for present quarter and one month ago projected EPS estimate was at $0.62. If we take a look at back 3 month ago, consensus EPS estimate was $0.62.
A current consensus EPS estimate for next quarter is at $0.54 and 3 month ago EPS forecast was $0.54. Have a look at back 1 month ago, consensus EPS forecast was seen at $0.54.
For current fiscal year, most recent EPS estimate is set at $2.46 based on Analyst consensus and three month ago consensus EPS opinions was at $2.43. During period one month ago, consensus EPS forecast was decided at $2.46.
A current consensus EPS projection for next fiscal year is observed at $2.65 and one month ago consensus EPS forecast was at $2.64. Take a look at back three month ago, consensus EPS estimate opinions was decided at $2.62 by analysts.
One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 11 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 4. 8 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 0.
Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 12 said a “Buy Rating” and 3 announced “Overweight Rating”. 9 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.